Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Salonen

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Scandinavian Journal of Urology|April 1, 2014
Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VIIArto J Salonen, Kimmo Taari, Martti Ala-Opas, et al.
International Journal of Epidemiology|April 1, 1996
Perceived health status and morbidity and mortality: evidence from the Kuopio ischaemic heart disease risk factor studyG A Kaplan, D E Goldberg, S A Everson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|August 6, 2005
Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acidA Babiker, S Dzeletovic, B Wiklund, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 3, 2011
Mesoporous silicon microparticles as carriers for peptidesM Kilpeläinen, J Mönkäre, J Riikonen, et al.
Journal of Occupational and Environmental Hygiene|July 24, 2009
Man-made vitreous fibers in office buildings in the Helsinki areaHeidi J Salonen, Sanna K Lappalainen, Henri M Riuttala, et al.
British Medical Journal|November 10, 1979
Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project)P Puska, J Tuomilehto, J Salonen, et al.
European Journal of Haematology|February 8, 2005
Bronchoalveolar lavage in immunocompromised patients with haematological malignancy--value of new microbiological methodsU Hohenthal, M Itälä, J Salonen, et al.
British Journal of Clinical Pharmacology|May 1, 1988
Lisinopril: dose-peak effect relationship in essential hypertensionV J Cirillo, H J Gomez, J Salonen, et al.
Journal of Materials Chemistry. B|April 9, 2020
Antibacterial properties of nitric oxide-releasing porous silicon nanoparticlesM Hasanzadeh Kafshgari, B Delalat, F J Harding, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 7, 2009
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticlesM Kilpeläinen, J Riikonen, M A Vlasova, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Scandinavian Journal of Urology|April 1, 2014
Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VIIArto J Salonen, Kimmo Taari, Martti Ala-Opas, et al.
International Journal of Epidemiology|April 1, 1996
Perceived health status and morbidity and mortality: evidence from the Kuopio ischaemic heart disease risk factor studyG A Kaplan, D E Goldberg, S A Everson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|August 6, 2005
Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acidA Babiker, S Dzeletovic, B Wiklund, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 3, 2011
Mesoporous silicon microparticles as carriers for peptidesM Kilpeläinen, J Mönkäre, J Riikonen, et al.
Journal of Occupational and Environmental Hygiene|July 24, 2009
Man-made vitreous fibers in office buildings in the Helsinki areaHeidi J Salonen, Sanna K Lappalainen, Henri M Riuttala, et al.
British Medical Journal|November 10, 1979
Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project)P Puska, J Tuomilehto, J Salonen, et al.
European Journal of Haematology|February 8, 2005
Bronchoalveolar lavage in immunocompromised patients with haematological malignancy--value of new microbiological methodsU Hohenthal, M Itälä, J Salonen, et al.
British Journal of Clinical Pharmacology|May 1, 1988
Lisinopril: dose-peak effect relationship in essential hypertensionV J Cirillo, H J Gomez, J Salonen, et al.
Journal of Materials Chemistry. B|April 9, 2020
Antibacterial properties of nitric oxide-releasing porous silicon nanoparticlesM Hasanzadeh Kafshgari, B Delalat, F J Harding, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 7, 2009
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticlesM Kilpeläinen, J Riikonen, M A Vlasova, et al.
Pageof 10